PharmaCyte Biotech Inc (NASDAQ:PMCB)

3.03
Delayed Data
As of Nov 25
 -0.04 / -1.30%
Today’s Change
1.79
Today|||52-Week Range
3.10
+21.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
--

Company Description

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Contact Information

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway
Las Vegas Nevada 89169
P:(917) 595-2850
Investor Relations:

Employees

Shareholders

Mutual fund holders4.30%
Other institutional26.20%
Individual stakeholders0.73%

Top Executives

Joshua Nathaniel SilvermanChairman, President & Chief Executive Officer
Carlos A. TrujilloChief Financial Officer
José L. IglesiasChief Medical Officer
Lilli BrandtnerDirector-Diabetes Program Development